Workflow
嘉应制药:9月11日融资净买入207.87万元,连续3日累计净买入2189.3万元

Group 1 - The core point of the news is that Jiaying Pharmaceutical (002198) has seen a significant increase in financing activities, with a net financing purchase of 2.07 million yuan on September 11, 2025, and a total net purchase of 21.89 million yuan over the last three trading days [1][2][3] - As of September 11, 2025, the financing balance for Jiaying Pharmaceutical reached 251 million yuan, representing a 0.84% increase from the previous day [2][3] - The financing net purchases for the last three trading days were as follows: 17.92 million yuan on September 9, 2025, 1.89 million yuan on September 10, 2025, and 2.07 million yuan on September 11, 2025 [2][3] Group 2 - The financing balance as a percentage of the circulating market value was 7.62% on September 11, 2025, indicating a growing interest from investors [2] - There were no short-selling transactions reported on September 11, 2025, suggesting a focus on financing rather than short-selling activities [1] - The overall financing and margin trading balance increased to 251 million yuan, reflecting a positive trend in investor sentiment towards Jiaying Pharmaceutical [3]